Indication
Hypokalemia prevention
Hypokalemia prevention refers to the prophylactic management aimed at averting an abnormally low serum potassium concentration, typically defined as falling below 3.5 mEq/L. Read more about Hypokalemia prevention
182 drugs 89 manufacturers
Drugs that treat it
Common Hypokalemia prevention therapies.
D5-LR WITH POTASSIUM CHLORIDE (potassium chloride in lactated ringers and 5 % dextrose)
KLOR-CON M10 (potassium chloride)
POTASSIUM GLUCONATE
POTASSIUM CHLORIDE
POTASSIUM CHLORIDE
0.9% NACL & POTASSIUM CHLORIDE (potassium chloride in 0.9 % sodium chloride)
D5W WITH POTASSIUM CHLORIDE (potassium chloride in 5 % dextrose in water)
D5 IN 0.45%NACL & POTASSIUM CL (potassium chloride in dextrose 5 %-0.45 % sodium chloride)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypokalemia prevention refers to the prophylactic management aimed at averting an abnormally low serum potassium concentration, typically defined as falling below 3.5 mEq/L.
This clinical indication predominantly applies to patient populations susceptible to excessive potassium depletion, such as individuals receiving non-potassium-sparing diuretic therapy, patients with persistent gastrointestinal losses, or those with hyperaldosteronism when dietary adjustments or medication reductions are insufficient.
Pathophysiologically, maintaining normal potassium homeostasis is essential for the resting membrane potential of excitable tissues; prophylaxis mitigates the risk of neuromuscular dysfunction, smooth muscle hypomotility, metabolic alkalosis, and life-threatening cardiac conduction abnormalities or arrhythmias.
- nih.gov
Hypokalemia prevention refers to the prophylactic management aimed at averting an abnormally low serum potassium concentration, typically defined as falling below 3.5 mEq/L
- fda.gov
Hypokalemia prevention refers to the prophylactic management aimed at averting an abnormally low serum potassium concentration, typically defined as falling below 3.5 mEq/L This clinical indication predominantly applies to patient populations susceptible to excessive potassium depletion, such as individuals receiving non-potassium-sparing diuretic therapy, patients with persistent gastrointestinal losses, or those with hyperaldosteronism when dietary adjustments or medication reductions are insu...
- aafp.org
This clinical indication predominantly applies to patient populations susceptible to excessive potassium depletion, such as individuals receiving non-potassium-sparing diuretic therapy, patients with persistent gastrointestinal losses, or those with hyperaldosteronism when dietary adjustments or medication reductions are insufficient
- nih.gov
Pathophysiologically, maintaining normal potassium homeostasis is essential for the resting membrane potential of excitable tissues; prophylaxis mitigates the risk of neuromuscular dysfunction, smooth muscle hypomotility, metabolic alkalosis, and life-threatening cardiac conduction abnormalities or arrhythmias
Personalize your experience
Follow Hypokalemia prevention and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.